Bitcoin News Update: Bitcoin ETFs Strengthen "Digital Gold" Reputation While Ethereum ETFs Experience Withdrawals
- Bitcoin ETFs saw $90.6M inflows on Oct 24, led by Fidelity’s FBTC ($57.9M) and BlackRock’s IBIT ($32.7M), ending a 5-day outflow streak and boosting Bitcoin’s price to $111,633. - Ethereum ETFs showed volatility, with $246M inflows on Oct 28 but $126M outflows the prior day, reflecting shifting institutional preferences toward Bitcoin as a stable store of value. - ETFs now hold 6.78% of Bitcoin’s $1.49T market cap vs. 5.55% for Ethereum, driven by Bitcoin’s deflationary model and growing gold correlation
On October 24, Bitcoin ETFs attracted $90.6 million in new investments, primarily fueled by institutional interest, with Fidelity's FBTC and BlackRock's
The positive trend persisted on October 28, with Bitcoin ETFs seeing $202.48 million in inflows. However,
Bitcoin’s rebound—an increase of nearly 8% from its October 11 low of $103,000—has been supported by liquidity from ETFs. Currently, ETF holdings make up 6.78% of Bitcoin’s $1.49 trillion market cap, compared to Ethereum ETFs’ 5.55% share of Ethereum’s $484.8 billion capitalization, as highlighted by TradingNews. Analysts attribute this divergence to Bitcoin’s deflationary supply and its rising correlation with gold (0.76), reinforcing its reputation as “digital gold.” Meanwhile, the outflows from Ethereum suggest that investors are reallocating funds to Bitcoin as a safeguard against currency depreciation and anticipated global rate cuts, another point emphasized by TradingNews.
Regulatory progress is also fueling the ETF surge. The U.S. Securities and Exchange Commission (SEC) is currently reviewing 155 cryptocurrency ETF proposals, including those for Bitcoin, Ethereum, and other digital assets, with approvals expected to speed up after the government shutdown, according to TradingNews. This regulatory clarity, combined with the Federal Reserve’s dovish stance, has accelerated institutional adoption. BlackRock’s IBIT, with $89.17 billion in AUM, and Fidelity’s FBTC, at $22.84 billion, now lead the industry, reflecting a maturing market where digital assets are becoming a staple in traditional investment portfolios, as detailed by TradingNews.
Market data further illustrates the stabilizing impact of ETFs. Bitcoin’s daily volatility has dropped from 62% in July to 39% in October, and the price gap between U.S. and European ETF markets has narrowed to less than 0.2%, as observed by TradingNews. Miners have also benefited, with weekly profitability rising 11% as ETF demand absorbs available supply, helping to support prices—another trend identified by TradingNews.
Looking forward, if daily inflows remain above $100 million, Bitcoin could reach $125,000–$130,000 by early November, provided regulatory and economic conditions stay favorable, according to TradingNews. In contrast, Ethereum may face short-term challenges, with analysts cautioning about possible price declines amid outflows and increased competition from layer-2 solutions, a risk previously highlighted by Blockchain News.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats
- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats
- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network
- Blockdaemon's Institutional Vault now supports Canton Coin, enabling secure custody and tokenization for institutions on the Canton Network. - 21shares launched a Canton Coin ETP on Euronext, offering investors institutional-grade exposure to privacy-focused blockchain innovation. - Canton Network's architecture, backed by J.P. Morgan and Goldman Sachs , facilitates secure, interoperable transactions while maintaining regulatory compliance. - Partnerships between blockchain infrastructure providers and t

LINK Price Moves to $13.90 as Market Tracks Tight Short-Term Structure
